Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 5 minute read Healthcare Industry News ZEISS gains CE mark for CIRRUS PathFinder AI tool to enhance ophthalmic scan decision support ZEISS earns CE mark for CIRRUS PathFinder, its integrated AI tool for OCT scan decision support. Find out how it could change ophthalmic diagnostics. byPallavi MadhirajuAugust 23, 2025